BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32912994)

  • 1. PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.
    Heinhuis KM; IJzerman NS; Koenen AM; van der Graaf WTA; Haas RL; Beijnen JH; Huitema ADR; van Houdt WJ; Steeghs N
    BMJ Open; 2020 Sep; 10(9):e039449. PubMed ID: 32912994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
    Embaby A; Heinhuis KM; IJzerman NS; Koenen AM; van der Kleij S; Hofland I; van Boven H; Sanders J; van der Graaf WTA; Haas RL; Huitema ADR; van Houdt WJ; Steeghs N
    Eur J Cancer; 2024 May; 202():113974. PubMed ID: 38452721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
    Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
    BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
    Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
    PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
    Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD
    EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol.
    Luczynska E; Rudnicki W; Kargol J; Szpor J; Hodorowicz-Zaniewska D; Wysocki PJ; Gorski M; Popiela TJ
    Breast J; 2021 Oct; 27(10):781-786. PubMed ID: 34263505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of propranolol in infantile haemangioma among Chinese children.
    Chik KK; Luk CK; Chan HB; Tan HY
    Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol targets the contractility of infantile haemangioma-derived pericytes.
    Lee D; Boscolo E; Durham JT; Mulliken JB; Herman IM; Bischoff J
    Br J Dermatol; 2014 Nov; 171(5):1129-37. PubMed ID: 24720697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
    Chow W; Amaya CN; Rains S; Chow M; Dickerson EB; Bryan BA
    JAMA Dermatol; 2015 Nov; 151(11):1226-9. PubMed ID: 26375166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Own experience in the treatment of infantile haemangiomas with propranolol - preliminary results.
    Przewratil P; Sitkiewicz A; Kierzkowska B; Lewandowska M; Lewandowska M; Andrzejowska E
    Med Wieku Rozwoj; 2011; 15(3 Pt 2):406-13. PubMed ID: 22253126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
    Wagner MJ; Othus M; Patel SP; Ryan C; Sangal A; Powers B; Budd GT; Victor AI; Hsueh CT; Chugh R; Nair S; Leu KM; Agulnik M; Sharon E; Mayerson E; Plets M; Blanke C; Streicher H; Chae YK; Kurzrock R
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34380663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.
    Porcelli L; Garofoli M; Di Fonte R; Fucci L; Volpicella M; Strippoli S; Guida M; Azzariti A
    Sci Rep; 2020 Jun; 10(1):10465. PubMed ID: 32591592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
    Phillips RJ; Lokmic Z; Crock CM; Penington A
    J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
    Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
    Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting.
    Chaturvedi K; Steinberg JS; Snyder CS
    Cardiol Young; 2018 Oct; 28(10):1105-1108. PubMed ID: 30047346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
    Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
    Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure.
    McSwiney E; Murray D; Murphy M
    Eur J Pediatr; 2014 Jan; 173(1):63-8. PubMed ID: 23933667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in the management of periorbital infantile haemangioma.
    Cheng JF; Gole GA; Sullivan TJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.